Abeona Therapeutics Inc (ABEO)
R&D to Revenue
44.12%
Quarterly · Period ending:
ABEO R&D to Revenue
Latest reported44.12%period ending
Latest reported44.12%period ending
ABEO Quarterly R&D/Revenue (166.67% → 44.12%)
Latest values, visible window
High-resolution chart · PNG
ABEO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10,320% | |
| 475.3555% | |
| 0% | |
| 0% | |
| 106,900% | |
| 0% | |
| 3,773.3333% | |
| 30,000% | |
| 0% | |
| 40,000% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 461.5385% | |
| 718.1818% | |
| 1,080% | |
| 357.1429% | |
| 0% | |
| 0% | |
| 0% | |
| 105.8824% | |
| 166.6667% |